Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.27.4 (
ribonuclease
)
6,621
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several members of the Wnt gene family have been shown to cause mammary tumors in mouse. Using degenerate primer polymerase chain reaction (PCR) on human genomic DNA, and specific PCR of cDNA libraries, we have isolated a WNT gene which has not previously been described in human. The gene is the human homologue of mouse Wnt10b, recently shown to be one of the oncogenes cooperating with FGF3 in the development of mouse mammary tumour virus (MMTV) induced mouse mammary carcinomas. The human
WNT10B
sequence was 88% and 95% identical to the murine gene at nucleotide and amino acid levels, respectively. YAC FISH mapping localises the gene to 12q13, a chromosomal region frequently rearranged in human tumours and also containing the WNT1 gene. In normal and benign proliferations of human breast tissue,
WNT10B
expression was not detected by
ribonuclease
protection assays but was found at low levels in RT-PCR experiments. In contrast, using both methods,
WNT10B
expression was found to be elevated in 3 of 50 primary breast carcinomas. Southern blot analysis of the carcinoma expressing the highest levels of
WNT10B
showed no amplification or rearrangement of the gene. The
WNT10B
gene was also expressed in some cancer and non cancerous breast cell lines. These findings suggest that the
WNT10B
gene may be involved in human breast cancer, and show that there is differential expression of the
WNT10B
gene in benign and malignant disease.
...
PMID:A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. 912 76